PMID- 11792863 OWN - NLM STAT- MEDLINE DCOM- 20020429 LR - 20211203 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 99 IP - 2 DP - 2002 Jan 22 TI - Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. PG - 1047-52 AB - The phosphorylation of a previously uncharacterized protein of apparent M(r) approximately 140,000 was found to be increased when rat adipocytes were incubated with insulin. The sequences of peptides generated by digesting the protein with trypsin matched perfectly with sequences in mouse lipin. Lipin is the product of the gene that is mutated in fatty liver dystrophy (fld) mice [Peterfy, M., Phan, J., Xu, P. & Reue, K (2001) Nat. Genet. 27, 121-124], which exhibit several phenotypic abnormalities including hyperlipidemia, defects in adipocyte differentiation, impaired glucose tolerance, and slow growth. When immunoblots were prepared with lipin antibodies, both endogenous adipocyte lipin and recombinant lipin overexpressed in HEK293 cells appeared as bands ranging in apparent M(r) from 120,000 to 140,000. Incubating adipocytes with insulin decreased the electrophoretic mobility and stimulated the phosphorylation of both Ser and Thr residues in lipin. The effects of insulin were abolished by inhibitors of phosphatidylinositol 3-OH kinase, and by rapamycin, a specific inhibitor of the mammalian target of rapamcyin (mTOR). The inhibition by rapamycin was blocked by FK506, which competitively inhibits those effects of rapamycin that are mediated by inhibition of mTOR. Moreover, amino acids, which activate mTOR, mimicked insulin by increasing lipin phosphorylation in a rapamycin-sensitive manner. Thus, lipin represents a target of the mTOR pathway, and potentially links this nutrient-sensing pathway to adipocyte development. FAU - Huffman, Todd A AU - Huffman TA AD - Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. FAU - Mothe-Satney, Isabelle AU - Mothe-Satney I FAU - Lawrence, John C Jr AU - Lawrence JC Jr LA - eng SI - GENBANK/AF412811 GR - R01 DK028312/DK/NIDDK NIH HHS/United States GR - R01 DK052753/DK/NIDDK NIH HHS/United States GR - DK28312/DK/NIDDK NIH HHS/United States GR - DK52723/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20020115 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Insulin) RN - 0 (Nuclear Proteins) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Recombinant Proteins) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.1.1 (mTOR protein, rat) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.1.3.4 (LPIN1 protein, human) RN - EC 3.1.3.4 (Lpin1 protein, mouse) RN - EC 3.1.3.4 (Phosphatidate Phosphatase) SB - IM MH - Adipocytes/metabolism MH - Amino Acid Sequence MH - Animals MH - Cell Line MH - Humans MH - In Vitro Techniques MH - Insulin/*pharmacology MH - Male MH - Mice MH - Molecular Sequence Data MH - Molecular Weight MH - Nuclear Proteins/chemistry/genetics/*metabolism MH - Phosphatidate Phosphatase MH - Phosphorylation MH - Protein Kinases/*metabolism MH - *Protein Serine-Threonine Kinases MH - Proto-Oncogene Proteins/metabolism MH - Proto-Oncogene Proteins c-akt MH - Rats MH - Recombinant Proteins/chemistry/genetics/metabolism MH - Signal Transduction MH - TOR Serine-Threonine Kinases PMC - PMC117427 EDAT- 2002/01/17 10:00 MHDA- 2002/05/01 10:01 PMCR- 2002/07/22 CRDT- 2002/01/17 10:00 PHST- 2002/01/17 10:00 [pubmed] PHST- 2002/05/01 10:01 [medline] PHST- 2002/01/17 10:00 [entrez] PHST- 2002/07/22 00:00 [pmc-release] AID - 022634399 [pii] AID - 6343 [pii] AID - 10.1073/pnas.022634399 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):1047-52. doi: 10.1073/pnas.022634399. Epub 2002 Jan 15.